Avid Bioservices Inc (CDMO)
6.67
+0.26
(+4.06%)
USD |
NASDAQ |
Apr 23, 16:00
6.69
+0.02
(+0.30%)
After-Hours: 20:00
Avid Bioservices Revenue (Quarterly): 25.40M for Oct. 31, 2023
Revenue (Quarterly) Chart
Historical Revenue (Quarterly) Data
| Date | Value |
|---|---|
| October 31, 2023 | 25.40M |
| July 31, 2023 | 37.73M |
| April 30, 2023 | 39.80M |
| January 31, 2023 | 38.02M |
| October 31, 2022 | 34.76M |
| July 31, 2022 | 36.69M |
| April 30, 2022 | 31.23M |
| January 31, 2022 | 31.51M |
| October 31, 2021 | 26.11M |
| July 31, 2021 | 30.75M |
| April 30, 2021 | 27.61M |
| January 31, 2021 | 21.81M |
| October 31, 2020 | 21.06M |
| July 31, 2020 | 25.39M |
| April 30, 2020 | 12.55M |
| January 31, 2020 | 13.58M |
| October 31, 2019 | 18.31M |
| July 31, 2019 | 15.25M |
| April 30, 2019 | 17.06M |
| January 31, 2019 | 13.78M |
| October 31, 2018 | 10.18M |
| July 31, 2018 | 12.59M |
| April 30, 2018 | 6.943M |
| January 31, 2018 | 6.819M |
| October 31, 2017 | 12.78M |
| Date | Value |
|---|---|
| July 31, 2017 | 27.08M |
| April 30, 2017 | 17.90M |
| January 31, 2017 | 10.75M |
| October 31, 2016 | 23.37M |
| July 31, 2016 | 5.609M |
| April 30, 2016 | 18.45M |
| January 31, 2016 | 6.709M |
| October 31, 2015 | 9.523M |
| July 31, 2015 | 9.671M |
| April 30, 2015 | 9.308M |
| January 31, 2015 | 5.677M |
| October 31, 2014 | 6.30M |
| July 31, 2014 | 5.496M |
| April 30, 2014 | 6.474M |
| January 31, 2014 | 3.885M |
| October 31, 2013 | 7.354M |
| July 31, 2013 | 4.688M |
| April 30, 2013 | 4.254M |
| January 31, 2013 | 7.039M |
| October 31, 2012 | 6.139M |
| July 31, 2012 | 4.251M |
| April 30, 2012 | 2.065M |
| January 31, 2012 | 3.281M |
| October 31, 2011 | 4.232M |
| July 31, 2011 | 5.655M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Quarterly) Range, Past 5 Years
12.55M
Minimum
Apr 2020
39.80M
Maximum
Apr 2023
26.56M
Average
26.11M
Median
Oct 2021
Revenue (Quarterly) Benchmarks
| Emergent BioSolutions Inc | 269.90M |
| Creative Medical Technology Holdings Inc | 0.003M |
| Viking Therapeutics Inc | -- |
| Stereotaxis Inc | 4.565M |
| MAIA Biotechnology Inc | -- |
Revenue (Quarterly) Related Metrics
| Net Income (Quarterly) | -9.509M |
| Total Expenses (Quarterly) | 36.62M |
| EPS Diluted (Quarterly) | -0.15 |
| Enterprise Value | 531.54M |
| Gross Profit Margin (Quarterly) | -18.37% |
| Profit Margin (Quarterly) | -37.44% |
| Earnings Yield | -2.62% |
| Normalized Earnings Yield | -2.623 |